Prescription drug · ANDA
Piperacillin and Tazobactam NDC 65219-259
Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL · Injection, Powder, Lyophilized, For solution · Intravenous · Fresenius Kabi USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65219-259-45 | 6521902594565219025945 | 10 VIAL, SINGLE-USE in 1 CARTON (65219-259-45) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-05)Marketed from May 18, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Piperacillin and Tazobactam
- Generic name (nonproprietary)
- piperacillin and tazobactam
- Active ingredients
- Piperacillin sodium — 4 g/20mLTazobactam sodium — .5 g/20mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Fresenius Kabi USA, LLCNDC labeler code 65219
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203719
- Marketing start
- Listing expires
- Other FDA classes
- Penicillins (Chemical structure)beta Lactamase Inhibitors (Mechanism)
- Identifiers
- Product ID 65219-259_3a3e13da-9eda-44fc-b274-119722634878SPL ID 3a3e13da-9eda-44fc-b274-119722634878
- Pharmacologic class
- Penicillin-class Antibacterial; beta Lactamase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N465219025945followed by a unit qualifier and the quantityPackage 65219-0259-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 65219-259
- What is NDC 65219-259?
- 65219-259 is the product NDC for Piperacillin and Tazobactam, Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Piperacillin and Tazobactam.
- What is the active ingredient?
- Piperacillin sodium, Tazobactam sodium.
- Who is the labeler?
- Fresenius Kabi USA, LLC, NDC labeler code 65219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Piperacillin and Tazobactam?
- 59 other product NDCs are listed under this name. See all Piperacillin and Tazobactam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Piperacillin and Tazobactam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| piperacillin and tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | Civica, Inc. | 72572-414 | 72572-0414-10 |
| piperacillin and tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | Civica, Inc. | 72572-418 | 72572-0418-10 |
| Piperacillin and Tazobactam | Piperacillin sodium 36 g/180mL; Tazobactam sodium 4.5 g/180mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-112 | 83634-0112-99 |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-104 | 83634-0104-20 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-105 | 83634-0105-30 |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | Avenacy, LLC | 83634-106 | 83634-0106-50 |
| Piperacillin and Tazobactampiperacillin sodium and tazobactam sodium | Piperacillin sodium 36 g/250mL; Tazobactam sodium 4.5 g/250mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | 55150-473 | 55150-0473-01 |
| Piperacillin and Tazobactampiperacillin sodium and tazobactam sodium | Piperacillin sodium 12 g/100mL; Tazobactam sodium 1.5 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | 55150-474 | 55150-0474-01 |
| Piperacillin and Tazobactam | Tazobactam sodium 4.5 g/180mL; Piperacillin sodium 36 g/180mL | Injection, Powder, Lyophilized, For solutionIntravenous | Apotex Corp. | 60505-6262 | 60505-6262-00 |
| Piperacillin and Tazobactam | Tazobactam sodium 4.5 g/180mL; Piperacillin sodium 36 g/180mL | Injection, Powder, Lyophilized, For solutionIntravenous | Shandong Anxin Pharmaceutical Co., Ltd. | 35369-0504 | 35369-0504-01 |
Other NDCs under ANDA 203719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-981 |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-982 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-983 |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | 65219-434 |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | 65219-436 |